Application

19447664 · Modulation of Apolipoprotein C-III (ApoCIII) Expression in Lipoprotein Lipase Deficient (LPLD) Populations

Filed 2026-01-13 · Abandoned The official file ↗ · Art unit 1637 · Examiner Ekaterina Poliakova-Georgan Typical · CPC A61K 31/7088 · Ionis Pharmaceuticals, Inc. · Arnold & Porter - Ionis

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

3.2 mo

to disposition 5.8 mo

Statutes raised

103 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.